Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the Context of G6PD Deficiency Genotype

Glucose‐6‐phosphate dehydrogenase (G6PD) deficiency is associated with development of acute hemolytic anemia (AHA) induced by a number of drugs. We provide guidance as to which G6PD genotypes are associated with G6PD deficiency in males and females. Rasburicase is contraindicated in G6PD‐deficient p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Relling, M V, McDonagh, E M, Chang, T, Caudle, K E, McLeod, H L, Haidar, C E, Klein, T, Luzzatto, L
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2014
Matèries:
CPIC Guidelines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4111801/
https://ncbi.nlm.nih.gov/pubmed/24787449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2014.97
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars